Fortress Biotech earnings were -$50.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest FBIO earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$12.7M, up 31.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FBIO reported annual earnings of -$55.9M, with -18.6% growth.
What were Fortress Biotech's earnings last quarter?
On FBIO's earnings call on Invalid Date, Fortress Biotech (NASDAQ: FBIO) reported Q1 2025 earnings per share (EPS) of -$0.48, up 53.85% year over year. Total FBIO earnings for the quarter were -$12.72 million. In the same quarter last year, Fortress Biotech's earnings per share (EPS) was -$1.04.
As of the last Fortress Biotech earnings report, Fortress Biotech is currently losing money. Fortress Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$41.16 million, a 24.49% decrease year over year.
What was FBIO's earnings growth in the past year?
As of Fortress Biotech's earnings date in Invalid Date, Fortress Biotech's earnings has grown year over year. FBIO earnings in the past year totalled -$50.75 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.